Fundraising FoxFannin Goldenrod Holdings
Venture capitalActively deployingHouston · 2 people tracked
Find your way into Fannin Goldenrod Holdings
Sign up to see every warm intro you have to Fannin Goldenrod Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fannin Goldenrod Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Fannin Goldenrod Holdings is a venture fund manager based in Houston. SEC filings show 1 venture fund on record, most recently Fannin Goldenrod Holdings I, LLC ($4.6M offering) filed June 2026.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 2 people
from public directories
What they invest in
from 3 of 3 portfolio companiesBiotech ×3Healthtech ×3Medical Devices ×3Deep Tech ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 23 dated
Goldenrod Therapeutics develops brain-penetrant phosphodiesterase 4 inhibitors for neurological and neuropsychiatric disorders, focusing on overcoming tolerability limitations of earlier PDE4 inhibitors to address neuroinflammation.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Corey Hopkins(Chair of the Department of Pharmaceutical Sciences and Director of the Center for Drug Design and Innovation at UNMC)Dev Chatterjee(Executive Officer)inLeo Linbeck IV(Executive Officer)Mark Worscheh(Executive Officer, Director)in
BoardAtul Varadhachary(Executive Officer, Director)
Board seatLeo Linbeck III· per SEC Form D · $6.5M raise · filed Jun 2026
Procyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.
BiotechHealthtechMedical DevicesHouston, US
Reynolds, III M. Delagado(Director)Benjamin A. Hertzog(Executive Officer, Director)Dr. Fain(Founder/Executive)Jason J Heuring(Executive Officer)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
Board seatLeo E Linbeck, III· per SEC Form D · $64M raise · filed Feb 2024
Co-investorsBluebird VenturesScientific Health DevelopmentTexas Ventures
Pulmotect develops immunomodulatory inhaled therapies designed to activate the lungs' innate immune system for preventing and treating respiratory complications in immunosuppressed patients and other high-risk populations.
BiotechHealthtechMedical DevicesHouston, US
Colin Broom(Executive Officer, Director)in
BoardKumar Srinivasan(Director)Atul Varadhachary(Director)Brenton Scott(President and Chief Operating Officer, Co-founder)Mark Worscheh(Director)in
Board seatLeo E. LinbeckLeo E. Linbeck IIILeo Linbeck III· per SEC Form D · filed Sep 2024
Co-investorsTexas Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Goldenrod Therapeutics, Inc. · finsmes.com · Jun 8, 2026
Frequently asked questions
- Where is Fannin Goldenrod Holdings located?
- Fannin Goldenrod Holdings is headquartered in Houston, US.